- Home
- FBIO vs VTGN Comparison
FBIO vs VTGN Comparison
Compare FBIO & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIO
- VTGN
- Stock Information
- Founded
- FBIO 2006
- VTGN 1998
- Country
- FBIO United States
- VTGN United States
- Employees
- FBIO N/A
- VTGN N/A
- Industry
- FBIO Biotechnology: Pharmaceutical Preparations
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- FBIO Health Care
- VTGN Health Care
- Exchange
- FBIO Nasdaq
- VTGN Nasdaq
- Market Cap
- FBIO 58.3M
- VTGN 59.8M
- IPO Year
- FBIO N/A
- VTGN N/A
- Fundamental
- Price
- FBIO $1.97
- VTGN $3.08
- Analyst Decision
- FBIO Strong Buy
- VTGN
- Analyst Count
- FBIO 2
- VTGN 0
- Target Price
- FBIO $21.00
- VTGN N/A
- AVG Volume (30 Days)
- FBIO 219.9K
- VTGN 405.3K
- Earning Date
- FBIO 08-12-2025
- VTGN 08-12-2025
- Dividend Yield
- FBIO N/A
- VTGN N/A
- EPS Growth
- FBIO N/A
- VTGN N/A
- EPS
- FBIO N/A
- VTGN N/A
- Revenue
- FBIO $57,784,000.00
- VTGN $486,000.00
- Revenue This Year
- FBIO $51.59
- VTGN $23.83
- Revenue Next Year
- FBIO $44.74
- VTGN $660.39
- P/E Ratio
- FBIO N/A
- VTGN N/A
- Revenue Growth
- FBIO N/A
- VTGN N/A
- 52 Week Low
- FBIO $1.33
- VTGN $1.90
- 52 Week High
- FBIO $2.66
- VTGN $3.79
- Technical
- Relative Strength Index (RSI)
- FBIO 55.60
- VTGN 75.81
- Support Level
- FBIO $1.90
- VTGN $2.25
- Resistance Level
- FBIO $2.02
- VTGN $2.83
- Average True Range (ATR)
- FBIO 0.10
- VTGN 0.21
- MACD
- FBIO -0.00
- VTGN 0.07
- Stochastic Oscillator
- FBIO 72.73
- VTGN 84.16
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.